Company intelligence / Profile preview

Histopath Consulting

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Histopath Consulting is a specialist contract research organization (CRO) providing expert histopathology and preclinical pathology services to the biotechnology and pharmaceutical industries. The company offers a comprehensive suite of services including tissue processing, routine and special staining, immunohistochemistry (IHC), and digital pathology analysis. Led by experienced veterinary and toxicologic pathologists, Histopath Consulting supports drug discovery and development programs by providing high-quality pathological assessments of animal models and human tissue samples. Their expertise is particularly focused on supporting preclinical safety, efficacy, and mechanism-of-action studies for novel therapeutic candidates.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Histopath Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histopath Consulting.

Explore the full profile